BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30926464)

  • 1. Clinical experience with dalbavancin for the treatment of deep sternal wound infection.
    Bartoletti M; Mikus E; Pascale R; Giannella M; Tedeschi S; Calvi S; Tenti E; Tumietto F; Viale P
    J Glob Antimicrob Resist; 2019 Sep; 18():195-198. PubMed ID: 30926464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dalbavancin treatment in a deep sternal wound MRSA infection after coronary artery bypass surgery: a case report.
    Guzek A; Suwalski G; Tomaszewski D; Rybicki Z
    J Cardiothorac Surg; 2018 Jan; 13(1):3. PubMed ID: 29304832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis.
    Barnea Y; Lerner A; Aizic A; Navon-Venezia S; Rachi E; Dunne MW; Puttagunta S; Carmeli Y
    J Antimicrob Chemother; 2016 Feb; 71(2):460-3. PubMed ID: 26518048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections.
    Khanlari B; Elzi L; Estermann L; Weisser M; Brett W; Grapow M; Battegay M; Widmer AF; Flückiger U
    J Antimicrob Chemother; 2010 Aug; 65(8):1799-806. PubMed ID: 20542908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative deep sternal wound infections: making an early microbiological diagnosis.
    Chaudhuri A; Shekar K; Coulter C
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1304-8. PubMed ID: 22241000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of negative pressure wound therapy followed by tissue flaps for deep sternal wound infection after cardiovascular surgery: propensity score matching analysis.
    Morisaki A; Hosono M; Murakami T; Sakaguchi M; Suehiro Y; Nishimura S; Sakon Y; Yasumizu D; Kawase T; Shibata T
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):397-402. PubMed ID: 27199380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study.
    Pascale R; Maccaro A; Mikus E; Baldassarre M; Tazza B; Esposito F; Rinaldi M; Tenti E; Ambretti S; Albertini A; Viale P; Giannella M; Bartoletti M
    J Glob Antimicrob Resist; 2022 Sep; 30():390-394. PubMed ID: 35878780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
    Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
    Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Microbiological Analysis of Deep Sternal Wound Infections in Fifty-Two Consecutive Patients.
    Spindler N; Biereigel C; Pieroh P; Schroeter T; Misfeld M; Josten C; Borger M; Rodloff AC; Langer S
    Surg Infect (Larchmt); 2020 May; 21(4):370-377. PubMed ID: 31809233
    [No Abstract]   [Full Text] [Related]  

  • 10. Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis.
    Gulmen S; Kurtoglu T; Meteoglu I; Kaya S; Okutan H
    J Surg Res; 2013 Nov; 185(1):64-9. PubMed ID: 23809152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin.
    Steele JM; Seabury RW; Hale CM; Mogle BT
    J Clin Pharm Ther; 2018 Feb; 43(1):101-103. PubMed ID: 28628223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. French national cohort of first use of dalbavancin: A high proportion of off-label use.
    Dinh A; Duran C; Pavese P; Khatchatourian L; Monnin B; Bleibtreu A; Denis E; Etienne C; Rouanes N; Mahieu R; Bouchand F; Davido B; Lotte R; Cabaret P; Camou F; Chavanet P; Assi A; Limonta S; Lechiche C; Riou R; Courjon J; Illes G; Lacassin-Beller F; Senneville E;
    Int J Antimicrob Agents; 2019 Nov; 54(5):668-672. PubMed ID: 31400471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gram-positive deep sternal wound infections in cardiac surgery--experiences with daptomycin.
    Popov AF; Schmitto JD; Jebran AF; Bireta C; Friedrich M; Rajaruthnam D; Coskun KO; Braeuer A; Hinz J; Tirilomis T; Schoendube FA
    J Cardiothorac Surg; 2011 Sep; 6():112. PubMed ID: 21929771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis.
    Silva V; Miranda C; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P
    Int J Antimicrob Agents; 2020 Jul; 56(1):106021. PubMed ID: 32439480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen.
    Werth BJ; Jain R; Hahn A; Cummings L; Weaver T; Waalkes A; Sengupta D; Salipante SJ; Rakita RM; Butler-Wu SM
    Clin Microbiol Infect; 2018 Apr; 24(4):429.e1-429.e5. PubMed ID: 28782651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
    Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
    Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological study of sternal osteomyelitis after median thoracotomy - a retrospective cohort study.
    Bota O; Taqatqeh F; Bönke F; Matschke K; Dragu A; Rasche S; Bienger K; Mülhausen M
    BMC Infect Dis; 2023 May; 23(1):349. PubMed ID: 37231332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
    Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
    J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulase-negative staphylococcal sternal wound infections after open heart operations.
    Mossad SB; Serkey JM; Longworth DL; Cosgrove DM; Gordon SM
    Ann Thorac Surg; 1997 Feb; 63(2):395-401. PubMed ID: 9033307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.